FDA Clears New Blood Clot Removal System for PE
The FDA cleared the Hēlo Thrombectomy System to remove blood clots from the lungs in patients with chronic venous thromboembolism.
The FDA cleared the Hēlo Thrombectomy System to remove blood clots from the lungs in patients with chronic venous thromboembolism.
The FDA cleared the Hēlo Thrombectomy System to remove blood clots from the lungs in patients with chronic venous thromboembolism.
Read MorePhiladelphia Eagles quarterback Jalen Hurts will likely miss the remainder of the NFL regular season after being diagnosed with DVT and bilateral pulmonary emboli.
Read MorePhysicians are less likely to prescribe recommended oral anticoagulants to patients facing housing insecurity or financial barriers, according to a Michigan Medicine study.
Read MoreThe new suite integrates workflows for COPD, lung nodules, and pulmonary embolism to improve patient follow-up and treatment times.
Read MoreA study of more than 32,000 CTPA scans found that artificial intelligence and physicians agreed on pulmonary embolism results nearly 98% of the time, though human review caught cases the software missed.
Read MoreBayer AG’s investigational drug asundexian reduced recurrent stroke risk by 26% in patients who recently experienced a stroke or temporary blockage of blood flow.
Read MoreA clinical trial found that minimally invasive endovascular therapy reduces symptoms of post-thrombotic syndrome after deep vein thrombosis.
Read MoreThe American Heart Association and American College of Cardiology issued their first joint clinical practice recommendations for acute pulmonary embolism.
Read MoreNASA’s Expedition 74 crew wrapped up the week with cardiac and respiratory studies and conducting space exercise research to keep astronauts healthy off the Earth.
Read MoreScientists have identified why some patients developed dangerous blood clots called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving certain COVID‑19 vaccines, or after natural adenovirus infection.
Read MoreThe ADLM issued guidance for coagulation testing in patients using direct oral anticoagulants (DOACs), including stroke, deep vein thrombosis, and pulmonary embolism.
Read MoreResearchers caution that COVID-19 history is an “additional risk factor” for VTE in patients undergoing panniculectomy to remove excess abdominal skin.
Read MoreA study of over 4,000 children found an unexpectedly high frequency of pulmonary embolism—equal to rates seen in adults.
Read MoreSonoVascular Inc’s SonoThrombectomy System is a catheter-based system that delivers ultrasound energy, microbubbles and thrombolytic drug to break down blood clots via an integrated mechanical-pharmacological approach.
Read MoreElevated sCD13 levels in COVID-19 patients’ lungs are associated with severe complications like respiratory failure and blood clot formation.
Read MoreAn NBA all-star for the Milwaukee Bucks will miss the remainder of the NBA regular season after being diagnosed with deep vein thrombosis (DVT).
Read MoreCardiorespiratory specialists warn discuss warning signs for pediatric emboli, which are on the rise, they say.
Read MoreGreater exposure to long-term air pollution was linked with increased risks for venous thromboembolism — blood clots that can occur in deep veins.
Read MoreThe San Antonio Spurs report center Victor Wembanyama has been diagnosed with deep vein thrombosis (DVT) in his shoulder and will miss the rest of the NBA’s regular season.
Read MoreArgon Medical Devices has enrolled the first patient in a US-based study exploring a novel catheter-based device for managing blood clots in the lungs.
Read MoreA therapeutic dose of anticoagulation with herapins also reduced the need for mechanical ventilation and the risk of thromboembolic events.
Read MoreThe likelihood of VTE was linked to anywhere from a 39% to a more than two-fold increased risk based on long-term exposure to three different types of air pollutants.
Read MoreThe CT-derived functional imaging software provides lung diagnostics without the need for contrast dye, which could benefit up to 30% of patients allergic to dye or with dye restrictions.
Read MoreThe clearance broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.
Read More